Solo gli utenti registrati possono tradurre articoli
Entra registrati
TECHNICAL FIELD
The present invention relates to macrocycles having activity against the hepatitis C virus (HCV) and useful in the treatment of HCV infections. More particularly, the invention relates to C5-substituted, proline-derived, macrocyclic compounds, compositions containing such compounds
Solo gli utenti registrati possono tradurre articoli
Entra registrati
TECHNICAL FIELD
The present invention relates to novel bicyclic compounds having activity against the hepatitis C virus (HCV) and useful in the treatment of HCV infections. More particularly, the invention relates to bicyclic, C5-substituted proline derivatives, compositions containing such
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
The present invention relates to novel hepatitis C virus ("HCV") protease inhibitors, pharmaceutical compositions containing one or more such inhibitors, methods of preparing such inhibitors and methods of using such inhibitors to treat hepatitis C and related disorders. This
Solo gli utenti registrati possono tradurre articoli
Entra registrati
2. TECHNICAL FIELD
The present disclosure relates to substantially stereomerically pure fused bicyclic proline compounds of structural Formulae II to VII:
##STR00002## in which A, M, M', and R.sup.5 are as described herein, to biocatalytic processes for their preparation, and to the biocatalytic
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
The present invention relates to novel hepatitis C virus ("HCV") protease inhibitors, pharmaceutical compositions containing one or more such inhibitors, methods of preparing such inhibitors and methods of using such inhibitors to treat hepatitis C and related disorders. This
Solo gli utenti registrati possono tradurre articoli
Entra registrati
TECHNICAL FIELD
The present invention relates to a nucleic acid comprising a chimeric gene derived from hepatitis C viruses, a chimeric hepatitis C virus particle of the JFH-1 strain and a strain other than the JFH-1 strain (preferably a strain of genotype 1a, 1b, or 2a), a vector used for producing
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
The present invention relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel peptides and analogues thereof, pharmaceutical compositions containing such peptides and methods for
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND
Hepatitis C virus (HCV) infection is estimated to affect 170 million individuals worldwide. This disease is primarily transmitted through contaminated blood products. Although its spread has been slowed as a result of improvement in blood screening in many countries, it remains the
Solo gli utenti registrati possono tradurre articoli
Entra registrati
JOINT RESEARCH AGREEMENT
Inventions described in this application were made by or on behalf of Enanta Pharmaceuticals, Inc. and Abbott Laboratories who are parties to a joint research agreement, that was in effect on or before the date such inventions were made and such inventions were made as a
Solo gli utenti registrati possono tradurre articoli
Entra registrati
JOINT RESEARCH AGREEMENT
Inventions described in this application were made by or on behalf of Enanta Pharmaceuticals, Inc. and Abbott Laboratories who are parties to a joint research agreement, that was in effect on or before the date such inventions were made and such inventions were made as a
Solo gli utenti registrati possono tradurre articoli
Entra registrati
TECHNICAL FIELD
The invention is directed to inhibitors of viral replication. In particular, it concerns the use of compounds related to the immunosuppressant macrolide FK506 to interfere with replication.
BACKGROUND ART
The macrolide FK506, which is of the formula: ##STR1## is manufactured by
Solo gli utenti registrati possono tradurre articoli
Entra registrati
TECHNICAL FIELD
The invention is directed to inhibitors of viral replication. In particular, it concerns the use of compounds related to the immunosuppressant macrolide FK506 to interfere with replication.
BACKGROUND ART
The macrolide FK506, which is of the formula: ##STR1## is manufactured by
Il database di erbe medicinali più completo supportato dalla scienza
Funziona in 55 lingue
Cure a base di erbe sostenute dalla scienza
Riconoscimento delle erbe per immagine
Mappa GPS interattiva - tagga le erbe sul luogo (disponibile a breve)
Leggi le pubblicazioni scientifiche relative alla tua ricerca
Cerca le erbe medicinali in base ai loro effetti
Organizza i tuoi interessi e tieniti aggiornato sulle notizie di ricerca, sperimentazioni cliniche e brevetti
Digita un sintomo o una malattia e leggi le erbe che potrebbero aiutare, digita un'erba e osserva le malattie ei sintomi contro cui è usata. * Tutte le informazioni si basano su ricerche scientifiche pubblicate